Bill > HRes685

This resolution expresses support for including testing for antiphospholipid syndrome (APS), an immune system condition that causes antibodies to increase blood clot risks, as a standard part of prenatal screening. The resolution highlights that APS can significantly impact pregnancy, potentially causing miscarriages, stillbirths, and other complications, and is responsible for approximately 15 percent of recurrent pregnancy losses. Currently, professional medical associations only recommend APS testing in specific circumstances, such as unexplained fetal loss after 10 weeks or three or more miscarriages. The resolution argues that APS can be detected through a simple blood test and treated with blood thinners, and that making APS testing routine during prenatal screenings could save babies' lives and reduce grief for women and families. Specifically, the resolution calls on the House of Representatives to support APS testing as a standard prenatal screening procedure and urges professional medical associations and guideline-setting bodies to update their recommendations to include routine APS testing.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-resolution/685/all-info